Myopathy, Centronuclear, Autosomal Recessive
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive centronuclear myopathy (ARCNM) is less characterized and has recently been associated to mutations in BIN1, encoding amphiphysin 2.
|
21129173 |
2010 |
Autosomal Recessive Centronuclear Myopathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Autosomal recessive centronuclear myopathy (ARCNM) is less characterized and has recently been associated to mutations in BIN1, encoding amphiphysin 2.
|
21129173 |
2010 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Amphiphysin 1 (AMPH-1) is a nerve terminals-enriched protein involved in endocytosis, and we observe that its expression is increased in breast cancer tumor in compared with normal breast.
|
29937937 |
2018 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
AMPH-1 is a tumor suppressor of lung cancer by inhibiting Ras-Raf-MEK-ERK signal pathway.
|
30143925 |
2019 |
Centronuclear myopathy
|
0.060 |
Biomarker
|
disease |
BEFREE |
Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.
|
30894500 |
2019 |
Congenital Structural Myopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.
|
30894500 |
2019 |
Osteofibrous Dysplasia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Amphiphysin 1 (AMPH-1) is involved in endocytosis, and its expression is upregulated in osteosarcoma compared with osteofibrous dysplasia.
|
31819629 |
2019 |
Infection caused by Helicobacter pylori
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
After adjusting for baseline diagnosis and H. pylori infection, methylation levels of AMPH, PCDH10, RSPO2, and ZNF610 had progression coefficients that increased and P values that decreased over 6, 12, and 16 years.
|
26269563 |
2015 |
Drug abuse
|
0.020 |
Biomarker
|
group |
BEFREE |
Although d-AMPH induces manic-like behavior, the mechanisms underlying these effects can also be related to phenotypes of drug abuse.
|
30699853 |
2019 |
Oropharyngeal candidiasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Analysis of nine severely defective mutants in a mouse model of OPC revealed that the strongest defects were seen for the <i>rvs161</i>Δ and <i>rvs167</i>Δ mutants, which lack amphiphysin proteins needed for endocytosis.
|
31719181 |
2019 |
Limbic Encephalitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anti-Amphiphysin-associated limbic encephalitis in a 72-year-old patient with aortic angiosarcoma.
|
30872337 |
2019 |
Aortic Angiosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anti-Amphiphysin-associated limbic encephalitis in a 72-year-old patient with aortic angiosarcoma.
|
30872337 |
2019 |
Lung Neoplasms
|
0.010 |
Biomarker
|
group |
LHGDN |
Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer.
|
16671079 |
2006 |
Autoimmune Diseases of the Nervous System
|
0.010 |
Biomarker
|
group |
BEFREE |
Autoantibodies against amphiphysin occur in patients afflicted with a rare neurologic autoimmune disease, paraneoplastic Stiff-Man syndrome.
|
7757077 |
1995 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
BIN1 is structurally related to amphiphysin, a breast cancer-associated autoimmune antigen, and RVS167, a negative regulator of the yeast cell cycle, suggesting roles in malignancy and cell cycle control.
|
8782822 |
1996 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
BIN1 is structurally related to amphiphysin, a breast cancer-associated autoimmune antigen, and RVS167, a negative regulator of the yeast cell cycle, suggesting roles in malignancy and cell cycle control.
|
8782822 |
1996 |
Lymphoma, Follicular
|
0.010 |
Biomarker
|
disease |
BEFREE |
Combined Bisulfite Restriction Analysis (COBRA) also established DNA methylation for the previously identified PRC2 targets DCC, DES, GAD2, AQP5, GPR61, GRIA4, GJD2, and AMPH in FL but not in BFH.
|
19530241 |
2009 |
Cognition Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice.
|
11879655 |
2002 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice.
|
11879655 |
2002 |
Centronuclear myopathy
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
|
20927630 |
2011 |
Amyotrophic Lateral Sclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Experiments were performed by inducing exocytosis in wild-type (WT) mice, in amphiphysin-I knockout (Amph-I KO) mice, which show impaired endocytosis, or in mice expressing high copy number of mutant human SOD1 with a Gly93Ala substitution (SOD1(G93A)), a model of human amyotrophic lateral sclerosis showing constitutively excessive Glu exocytosis.
|
25497732 |
2015 |
Gastrointestinal Stromal Tumors
|
0.010 |
Biomarker
|
group |
BEFREE |
Expression of synaptic-like microvesicle proteins, e.g., Synaptic vesicle protein 2 (SV2), synaptobrevin, synapsin 1, and amphiphysin was demonstrated in a majority of GISTs by immunohistochemistry, western blotting, and quantitative reversetranscriptase PCR.
|
17914114 |
2007 |
Esophageal Neoplasms
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.
|
22960999 |
2012 |
Centronuclear myopathy
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Here, we focused on amphiphysin 2 (BIN1, also known as bridging integrator-1) and dynamin 2 (DNM2), two ubiquitous proteins implicated in membrane remodeling and mutated in centronuclear myopathies (CNMs).
|
29130937 |
2017 |
Myopathy
|
0.030 |
Biomarker
|
group |
BEFREE |
However, the muscle-specific function of amphiphysin 2 and its pathogenicity in both muscle disorders are not well understood.
|
23754947 |
2013 |